AG-181 / Agios Pharma - LARVOL DELTA

AG181-C-001: A Safety Study of Single and Multiple Doses of AG-181 in Healthy Participants (clinicaltrials.gov) - P1 | N=120 | Recruiting | Sponsor: Agios Pharmaceuticals, Inc. | Trial completion date: Sep 2025 ➔ Jun 2025 | Trial primary completion date: Sep 2025 ➔ Jun 2025

Trial completion date • Trial primary completion date

AG181-C-001: Single and Multiple Ascending Dose Study and Pilot Food Effect Study for AG-181 (clinicaltrials.gov) - P1 | N=120 | Recruiting | Sponsor: Agios Pharmaceuticals, Inc.

New P1 trial